Atlas Bio has raised $10.0M in seed funding from Creandum. The biotech company runs in silico clinical trials in immunology, using a foundation AI model of human biology to predict and compare patient responses across treatments and indications. That gives biopharma teams a way to weigh what to advance, acquire, or expand before committing to costly trials. The company's stated mission is to de-risk clinical development by providing predictive evidence ahead of the real thing.
Atlas Bio Raises $10.0M Seed Round to Advance AI-Driven Clinical Trials
Get the full Atlas Bio company profile
Access contacts, investors, buying signals & more
From the source
tech.eu · Oct 27, 2026Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing - Tech.eu Biotech Swiss startup Atlas Bio secures $12.
5M to tackle drug development’s 70% failure rate and move beyond animal testing The Swiss startup is developing an AI foundation model that predicts drug efficacy and safety in virtual patients, potentially reducing years of clinical testing to weeks. Cate Lawrence 31 minutes ago Share Facebook Twitter Linkedin Swiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round
Other recently funded companies
View all
Wormsensing
Wormsensing designs, manufactures, and markets strain sensors and sensing solutions. Wormsensing has a unique know-how and a multi-patented technology to design and create sensors from scratch, starting from the raw materials developed in-house. The result is highly customizable products that only Wormsensing can make with unparalleled performance and integration capabilities. Dragonfly®, our first product, is the World’s thinnest piezoceramic sensor tailored for dynamic strain measurement. Its unique qualities make it a sensor of choice for plenty of application: Monitoring (SHM, CBM, etc.) – Event detection – Vibration analysis and investigation – Quality & process control – Dynamic weighing – Functionalization & HMI. Beyond Dragonfly® standard design, we offer custom solutions to directly integrate our sensing technology into our customers’ products, especially original equipment manufacturers (OEM). We established our production facility within sight of its scientific origins in Grenoble, France, where we invested in cutting-edge industrial equipment. Our current infrastructure ensures a production capacity of 2M sensors/year while allowing for continuous industrial innovation. We evolve within this unique ecosystem, surrounded by trusted partners, infused and believing in the power of Science, just as we do.
$10.6M Series a
today
Biggest recent Biotechnology rounds
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Omabit United States | Seed | $2.0M | today |
| 2 |  dubdub India | Seed | $1.3M | today |
